AUPP466598A0 - Product and process - Google Patents

Product and process

Info

Publication number
AUPP466598A0
AUPP466598A0 AUPP4665A AUPP466598A AUPP466598A0 AU PP466598 A0 AUPP466598 A0 AU PP466598A0 AU PP4665 A AUPP4665 A AU PP4665A AU PP466598 A AUPP466598 A AU PP466598A AU PP466598 A0 AUPP466598 A0 AU PP466598A0
Authority
AU
Australia
Prior art keywords
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP4665A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newcastle Innovation Ltd
Original Assignee
Newcastle Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newcastle Innovation Ltd filed Critical Newcastle Innovation Ltd
Priority to AUPP4665A priority Critical patent/AUPP466598A0/en
Publication of AUPP466598A0 publication Critical patent/AUPP466598A0/en
Priority to AU47634/99A priority patent/AU772501B2/en
Priority to JP2000560129A priority patent/JP2002520415A/en
Priority to CA002337771A priority patent/CA2337771A1/en
Priority to KR1020017000638A priority patent/KR20010074721A/en
Priority to PCT/AU1999/000567 priority patent/WO2000004023A1/en
Priority to EP99930941A priority patent/EP1104423A4/en
Priority to US10/703,336 priority patent/US20040110822A1/en
Priority to AU2004203476A priority patent/AU2004203476A1/en
Priority to US11/240,971 priority patent/US20060030616A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AUPP4665A 1998-07-14 1998-07-14 Product and process Abandoned AUPP466598A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPP4665A AUPP466598A0 (en) 1998-07-14 1998-07-14 Product and process
EP99930941A EP1104423A4 (en) 1998-07-14 1999-07-14 Anhydride modified cantharidin analogues useful in the treatment of cancer
KR1020017000638A KR20010074721A (en) 1998-07-14 1999-07-14 Anhydride modified cantharidin analogues useful in the treatment of cancer
JP2000560129A JP2002520415A (en) 1998-07-14 1999-07-14 Anhydrous modified cansalidin analogues useful for the treatment of cancer
CA002337771A CA2337771A1 (en) 1998-07-14 1999-07-14 Anhydride modified cantharidin analogues useful in the treatment of cancer
AU47634/99A AU772501B2 (en) 1998-07-14 1999-07-14 Anhydride modified cantharidin analogues useful in the treatment of cancer
PCT/AU1999/000567 WO2000004023A1 (en) 1998-07-14 1999-07-14 Anhydride modified cantharidin analogues useful in the treatment of cancer
US10/703,336 US20040110822A1 (en) 1998-07-14 2003-11-07 Anhydride modified cantharidin analogues useful in the treatment of cancer
AU2004203476A AU2004203476A1 (en) 1998-07-14 2004-07-29 Anhydride modified cantharidin analogues useful in the treatment of cancer
US11/240,971 US20060030616A1 (en) 1998-07-14 2005-09-30 Anhydride modified cantharidin analogues useful in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP4665A AUPP466598A0 (en) 1998-07-14 1998-07-14 Product and process

Publications (1)

Publication Number Publication Date
AUPP466598A0 true AUPP466598A0 (en) 1998-08-06

Family

ID=3808903

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP4665A Abandoned AUPP466598A0 (en) 1998-07-14 1998-07-14 Product and process

Country Status (6)

Country Link
EP (1) EP1104423A4 (en)
JP (1) JP2002520415A (en)
KR (1) KR20010074721A (en)
AU (1) AUPP466598A0 (en)
CA (1) CA2337771A1 (en)
WO (1) WO2000004023A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038043B4 (en) * 2000-08-02 2006-09-07 Walter, Michael, Dr. Phamacologically active substance for the treatment of cardiovascular diseases
AUPR392301A0 (en) * 2001-03-23 2001-04-26 University Of Newcastle Research Associates Limited, The Protein phosphatase inhibitors
US20040152766A1 (en) * 2001-05-31 2004-08-05 Au-Yeung Steven C.F. Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof
BR0314870A (en) * 2002-10-02 2005-08-02 Aventis Pharma Gmbh Hydroxyphenylundecane derivatives, process for their production and use
CN1623993A (en) * 2003-12-02 2005-06-08 北京键凯科技有限公司 Cantharides amine and demethyl cantharides amine derivative and application in medicine thereof
CN1304396C (en) * 2005-04-08 2007-03-14 中山大学 Derivative of canthardin and preparation method
RU2500673C2 (en) 2005-05-18 2013-12-10 Астразенека Аб Heterocyclic mek inhibitors and methods for use thereof
EP1736154A1 (en) * 2005-06-24 2006-12-27 Friedrich-Alexander-Universität Erlangen-Nürnberg Use of PP-1 inhibitors to prevent missplicing events
CN103788108B (en) 2007-02-06 2017-04-12 利克斯特生物技术公司 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
CA2730148C (en) 2008-08-01 2018-04-03 Lixte Biotechnology, Inc. Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
US8227473B2 (en) 2008-08-01 2012-07-24 Lixte Biotechnology, Inc. Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
CN105209036B (en) 2013-04-09 2018-10-26 莱克斯特生物技术公司 The preparation of oxa-bicyclo heptane and oxabicyclo heptene
KR101511857B1 (en) * 2013-11-01 2015-04-13 주식회사 엘지생활건강 A body hair growth inhibition composition comprising dimethyl cantharidin as an effective ingredient
CN104447782B (en) * 2014-12-30 2016-09-14 贵州柏强制药有限公司 Bromo norcantharidin mono-acid benzyl ester and synthetic method thereof and application
ES2788856T3 (en) 2017-03-20 2020-10-23 Forma Therapeutics Inc Compositions of pyrrolopyrrole as pyruvate kinase (PKR) activators
US11001588B2 (en) 2018-09-19 2021-05-11 Forma Therapeutics, Inc. Activating pyruvate kinase R and mutants thereof
EP3853206B1 (en) 2018-09-19 2024-04-10 Novo Nordisk Health Care AG Treating sickle cell disease with a pyruvate kinase r activating compound
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R
KR20240012182A (en) 2022-07-20 2024-01-29 고려대학교 산학협력단 Composition comprising the cantharidine compound for prevention or treatment of glioblastoma

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954913A (en) * 1975-01-06 1976-05-04 The Standard Oil Company Stabilized nitrile polymers
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
JPS63170383A (en) * 1987-02-26 1988-07-14 Nippon Zeon Co Ltd Alicyclic dicarboximide compound
DE4134758A1 (en) * 1991-10-22 1993-04-29 Bayer Ag NEW SUBSTITUTED TETRAHYDROFURANE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
DE4134755A1 (en) * 1991-10-22 1993-04-29 Bayer Ag USE OF PARTLY KNOWN SUBSTITUTED TETRAHYDROTHIOPHENES AS A MEDICINAL PRODUCT, NEW ACTIVE SUBSTANCES AND METHOD FOR THE PRODUCTION THEREOF
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
WO1995007022A1 (en) * 1993-09-07 1995-03-16 Zeneca Limited Fungicides
WO1995017901A1 (en) * 1993-12-29 1995-07-06 Matrix Pharmaceutical, Inc. Methods and compositions for the treatment of a host with a cellular proliferative disease

Also Published As

Publication number Publication date
JP2002520415A (en) 2002-07-09
WO2000004023A9 (en) 2000-04-20
KR20010074721A (en) 2001-08-09
CA2337771A1 (en) 2000-01-27
EP1104423A4 (en) 2001-10-24
EP1104423A1 (en) 2001-06-06
WO2000004023A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
AU5099599A (en) Bio-reaction process and product
AU6503299A (en) High-beta-conglycinin products and their use
AU6106999A (en) Process
AU1705500A (en) Product detector and method therefor
AU2312300A (en) Processing product components
AU3890299A (en) Cryo-sedimentation process
AU5784099A (en) Dairy product and process for making
AUPP466598A0 (en) Product and process
HU9900636D0 (en) Confectionery product and process
AU4380997A (en) Frozen product and process for the preparation thereof
EP1127060B8 (en) Hydroboronation process
AU5993996A (en) Touch-readable product and associated process
AU3198299A (en) Multi-carotenoid product
AUPP718098A0 (en) Bioxidation process and apparatus
AU1064800A (en) Products and methods
AU5377999A (en) Oil product and manufacturing process
AUPO752297A0 (en) Manufacturing process and apparatus
AUPO138196A0 (en) Meat product and methods for production thereof
AU6819598A (en) Anti-counterfeit method and product using the method
AU7764798A (en) Product and method for providing glutamine
AU2935699A (en) Process for the decoration of wall-tiles and floor-tiles
AU4231097A (en) Antimicrobial product and process
AUPQ165199A0 (en) Product and process
AU1223600A (en) Process
AU7023300A (en) Product and method

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 4763499

Country of ref document: AU